A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Clinical trial NCT03649971 · COMPLETED
Trial details
- NCT number
- NCT03649971
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-19
- Primary completion
- 2021-09-13
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.